Income Statement
CLIMB BIO, INC.
CLYM
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
67.88 | 82.02 | 40.28 | 45.14 | 35.67 |
|
Research & Development
|
46.71 | 66.00 | 15.41 | 26.21 | 22.05 |
|
Selling, General & Administrative
|
21.17 | 16.03 | 24.86 | 18.92 | 12.35 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-67.88 | -82.02 | -40.28 | -45.14 | -35.67 |
|
Non-Operating Income
|
- | - | - | - | - |
|
Interest Income
|
8.32 | 8.13 | - | - | - |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
8.03 | 8.12 | 5.16 | -0.11 | -11.81 |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-59.85 | -73.90 | -35.12 | -45.24 | -47.48 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-67.79 | -82.02 | -40.28 | -45.14 | -35.67 |
|
Earnings Per Share (Basic)
|
-0.88 | -1.53 | -1.30 | -1.72 | - |
|
Diluted EPS
|
-0.88 | -1.53 | -1.30 | -1.72 | - |
|
Weighted Average Shares
|
67.81 | 48.16 | 26.99 | 26.31 | - |
|
Diluted Weighted Avg Shares
|
67.81 | 48.16 | 26.99 | 26.31 | 12.26 |
|
Comprehensive Income
|
-59.44 | -73.87 | -34.76 | -45.48 | - |